Atlas Trials

A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)

Clinical trial NCT02452476 · COMPLETED

Trial details

NCT number
NCT02452476
Sponsor
Chiesi Farmaceutici S.p.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Distress Syndrome, Newborn
Start date
2016-01-21
Primary completion
2018-05-24
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.